Entrada Therapeutics (TRDA) Earnings Date & Reports
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TRDA is expected to report earnings to rise 6.32% to -100 cents per share on November 10
Q3'26
Est.
$-1.01
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.22
The last earnings report on May 07 showed earnings per share of -94 cents, beating the estimate of -101 cents. With 227.15K shares outstanding, the current market capitalization sits at 278.79M.